Skip to main content

Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy – a prospective clinical cardiovascular magnetic resonance trial



Segmented phase-sensitive inversion recovery (PSIR) cardiovascular magnetic resonance (CMR) sequences are reference standard for non-invasive evaluation of myocardial fibrosis using late gadolinium enhancement (LGE). Several multi-slice LGE sequences have been introduced for faster acquisition in patients with arrhythmia and insufficient breathhold capability.

The aim of this study was to assess the accuracy of several multi-slice LGE sequences to detect and quantify myocardial fibrosis in patients with ischemic and non-ischemic myocardial disease.


Patients with known or suspected LGE due to chronic infarction, inflammatory myocardial disease and hypertrophic cardiomyopathy (HCM) were prospectively recruited. LGE images were acquired 10–20 min after administration of 0.2 mmol/kg gadolinium-based contrast agent. Three different LGE sequences were acquired: a segmented, single-slice/single-breath-hold fast low angle shot PSIR sequence (FLASH-PSIR), a multi-slice balanced steady-state free precession inversion recovery sequence (bSSFP-IR) and a multi-slice bSSFP-PSIR sequence during breathhold and free breathing. Image quality was evaluated with a 4-point scoring system. Contrast-to-noise ratios (CNR) and acquisition time were evaluated. LGE was quantitatively assessed using a semi-automated threshold method. Differences in size of fibrosis were analyzed using Bland-Altman analysis.


Three hundred twelve patients were enrolled (n = 212 chronic infarction, n = 47 inflammatory myocardial disease, n = 53 HCM) Of which 201 patients (67,4%) had detectable LGE (n = 143 with chronic infarction, n = 27 with inflammatory heart disease and n = 31 with HCM). Image quality and CNR were best on multi-slice bSSFP-PSIR. Acquisition times were significantly shorter for all multi-slice sequences (bSSFP-IR: 23.4 ± 7.2 s; bSSFP-PSIR: 21.9 ± 6.4 s) as compared to FLASH-PSIR (361.5 ± 95.33 s). There was no significant difference of mean LGE size for all sequences in all study groups (FLASH-PSIR: 8.96 ± 10.64 g; bSSFP-IR: 8.69 ± 10.75 g; bSSFP-PSIR: 9.05 ± 10.84 g; bSSFP-PSIR free breathing: 8.85 ± 10.71 g, p > 0.05).

LGE size was not affected by arrhythmia or absence of breathhold on multi-slice LGE sequences.


Fast multi-slice and standard segmented LGE sequences are equivalent techniques for the assessment of myocardial fibrosis, independent of an ischemic or non-ischemic etiology. Even in patients with arrhythmia and insufficient breathhold capability, multi-slice sequences yield excellent image quality at significantly reduced scan time and may be used as standard LGE approach.

Trial registration

ISRCTN48802295 (retrospectively registered).


Late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) is a well-established method for assessment of focal myocardial fibrosis and scarring in ischemic and non-ischemic cardiomyopathies [1,2,3,4]. The presence and extent of LGE has been shown to be associated with worse patient outcome in a variety of diseases, i.e. myocardial infarction, hypertrophic cardiomyopathy (HCM) and acute or chronic inflammatory heart disease [5,6,7]. Hence, the assessment of LGE is integrated into many clinical guidelines and is an integral part of most contrast-based CMR protocols [8,9,10].

The reference standard technique for LGE assessment is typically based on phase-sensitive inversion recovery (PSIR) sequences that are acquired in a single-slice, single-breathhold fashion [11, 12]. These segmented PSIR LGE images generate excellent image quality at a high spatial resolution if the individual patient has sufficient breathhold capabilities and is in sinus rhythm [13].

However, with the more widespread use of CMR in clinical routine increasing numbers of patients referred for CMR present with arrhythmias or an inability for sufficient breathhold for CMR scan. In these patients, conservative segmented PSIR LGE sequences sometimes fail to provide satisfactory image quality for accurate assessment.

Furthermore, standard segmented LGE sequences typically require 5 to 10 min of scan time for complete myocardial coverage. There is a need for faster and more efficient imaging in CMR in order to enable a more wide-spread use of CMR in clinical routine as well as in smaller institutions where access to CMR scanners maybe more restricted [14]. CMR also competes with other non-invasive imaging techniques in terms of scan time optimization leading to efforts for faster standardized CMR scan protocols [15].

In order to address these issues, multi-slice LGE sequences have been developed with acquisition of the entire k-space of an individual image slice within one heart cycle [16]. Different approaches utilize navigator-based, free breathing sequencing which works without breathhold but mostly still requires stable heart rhythm for optimal image quality [17].

Several small clinical studies have shown that multi-slice LGE sequences provide similar image quality to standard segmented LGE sequences [18, 19]. However, the vast majority of these studies investigated only patients with a single disease entity, i.e. myocardial infarction or HCM and/or excluded patients with arrhythmia. Hence, these studies are not reflecting clinical reality where the underlying cause of LGE is often not known prior to the CMR scan and sinus rhythm is often unstable or non-existent.

In this prospective study we intended to determine the comparability of standard segmented PSIR LGE imaging with two different multi-slice LGE sequences with and without breathhold in a large number of patients with ischemic and non-ischemic cardiomyopathy, namely chronic myocardial infarction, HCM and inflammatory heart disease. Furthermore, we explicitly did not exclude patients with arrhythmia. We aimed to assess if multi-slice LGE sequences represent a robust alternative for LGE assessment independent of pathophysiologic origin of LGE, heart rhythm and patient breathhold capabilities.


Study population

312 consecutive patients with known or suspected LGE were prospectively recruited. All patients were referred for clinical LGE assessment using CMR for both, ischemic and non-ischemic cardiomyopathies, based on the clinical information provided by the referring cardiologist. A total of 212 patients had chronic myocardial infarction, 53 patients had HCM and 47 patients had inflammatory heart disease.

All patients underwent a single CMR scan with three different LGE sequences. Exclusion criteria were contraindications to CMR and severe chronic renal disease with an estimated glomerular filtration rate < 30 ml/min/1.73m2. All studies were performed in accordance with the local institutional review board and local ethics committee approval.

Image protocol

All CMR studies were performed on a 1.5 Tesla scanner (AvantoFit®, Siemens Healthineers, Erlangen, Germany). Patients were scanned with electrocardiogram (ECG)-triggering in the supine position using 16-channel surface phased array coils.

All imaging protocols included assessment of myocardial function in balanced steady-state free precession (bSSFP) cine sequences and of myocardial morphology by LGE imaging.

bSSFP cine imaging (TE 1.19 ms, TR 33.36 ms, flip angle 55°, retrospective ECG-triggered gating, matrix 192x156mm, FOV 340 mm, slice thickness 6 mm, bandwidth 930 Hz, 30 phases per heart cycle, iPAT GRAPPA acceleration factor 2) was performed in long axis two- and four-chamber view for biplanar assessment of left ventricular (LV) end-diastolic volume (LVEDV), LV mass (LVM) and LV ejection fraction (LVEF). Contours were drawn manually and biplanar anatomical and functional parameters calculated automatically by the post-processing software according to an established in-line biplane ellipsoid model. [20] The standard three-point method was used on short axis localizers to define standardized long axis two-chamber (one point in the LV apex, one point in the anterior and one point in the inferior wall of the lv myocardium in the slice with the maximum LV area) and four-chamber view (one point in the LV apex, one point in the interatrial septum below the aorta and one point into the most lateral corner of the right ventricle (RV) on the short axis localizer with the maximum RV area).

For LGE imaging, a 0.2 mmol/kg intravenous injection of contrast agent was administered into an antecubital vein. In patients with myocardial infarction or HCM assessment gadoteridol (ProHance®, Bracco S.p.A., Milan, Italy) was used. For patient with known or suspected inflammatory heart disease gadopentetate (Magnevist®, Bayer Healthcare, Wayne, New Jersey, USA) was administered due to established normal values for this contrast agent for the early enhancement technique which was clinically assessed in these patients independently from this study [21].

Ten minutes after contrast administration, a segmented IR cine bSSFP inversion time (TI) scouting sequence was performed at a mid-ventricular short axis location to determine optimal TI [22]. TI was adapted to optimally null the signal of the remote myocardium. Two-dimensional LGE images were acquired in short-axis views covering the entire LV myocardium by using three different LGE sequences: i) a segmented, single-slice, single-breathhold 2D FLASH-based phase-sensitive inversion recovery sequence (FLASH-PSIR) which was considered as the reference standard; ii) a multi-slice 2D bSSFP-based inversion recovery sequence (bSSFP-IR); iii) a multi-slice 2D bSSFP-based PSIR sequence (bSSFP-PSIR).

Sequence details are displayed in Table 1.

Table 1 LGE sequence parameters

All LGE sequences were acquired in end-expiratory breathhold while the bSSFP-PSIR sequence was additionally acquired in free breathing. In case of suspected artifacts in the LGE images a second perpendicular slice through the affected region was acquired or read-out of the phase encoding direction was swapped. Segmented and multi-slice LGE images were acquired in random order. Acquisition times and occurrence of arrhythmia during image acquisition were noted for all sequences.

Qualitative and quantitative image analysis

For all post-processing analyses commercially available software was used (CVI42 Release 5.6.2, Circle Cardiovascular Imaging, Calgary, Canada). A blinded reader performed LV function assessment in bSSFP cine long axis slices. For assessment of LVEF endocardial contours were drawn in the end-diastolic and end-systolic phase of two- and four-chamber view. All parameters were automatically calculated after contouring by the post-processing software. Separately, image quality and quantitative LGE assessment were performed in a random and blinded order.

For 30 randomly selected individuals, the same reader and a second experienced reader repeated analyses for assessment of intra- and interobserver variability.

Image quality

Visual assessment of image quality was performed on all LGE sequences for each patient using a previously established 4-point-scale using the following grading: excellent quality, no artifacts (score of 1); good quality, minimal artifacts (score of 2); moderate quality, some artifacts which may impair diagnostic quality (score of 3); poor quality, unacceptable artifacts (score of 4) [19].

Signal intensities were measured in regions of interest (ROIs) that covered areas of contrast-enhanced myocardium, as well as areas of remote non-enhanced myocardium with an additional ROI located outside the patient for calculation of background noise. Signal enhancement was measured as recommended by Simonetti et al. [12].

In detail, we calculated signal intensities and their standard deviations in ROIs of LGE-positive myocardium, as well as areas of remote myocardium. Contrast was defined as difference between mean signal intensity of both ROIs. Image noise was defined as the standard deviation of the signal intensity in the normal-appearing myocardium ROI. Contrast-to-noise ratios (CNR) were calculated by using these values. Measurement of signal-to-noise ratios (SNR) is limited on PSIR images conventionally because the measurement of background noise is invalid in the reconstructed images [23]. Therefore, we did not perform SNR assessment.

Visual LGE assessment

The distribution area and transmurality of fibrosis was evaluated according to the American Heart Association (AHA) 16-segment model. The distribution area of scar in each segment was scored by the proportion of scar to each segment (0: no LGE, 1: 1–25%, 2: 26–50%, 3: 51–75%, 4: 76–100%).

For each subject, the number of segments with presence or absence of fibrosis and location within the myocardial wall (subendocardial, intramural, subepicardial, transmural) was noted for each LGE sequence as previously described [24].

Quantitative LGE assessment

Quantification of LGE was performed with the established semi-automated signal threshold versus reference mean (STRM) method as published previously by our and other groups [21, 25, 26]. On all LGE images, endocardial and epicardial contours were manually traced and ROIs were defined in hyperenhanced and remote myocardium.

True LGE was defined by myocardial signal intensity plus 6 standard deviations (SD) above that of remote, normal-appearing myocardium within the same slice in patients with myocardial infarction. For subjects with HCM and inflammatory heart disease, plus 3 SDs were defined as true LGE [27].

The automated LGE detection could be manually corrected by the reader for a specific location to exclude obvious artifacts. After segmentation, myocardial and scar tissue mass (in grams) were calculated and compared for each AHA segment in each sequence.

Statistical analysis

All statistical analyses were conducted by using statistical software package SPSS 17.0 (International Business Machines, Armonk, New York, USA). Quantitative data are expressed as means ± SD. Sample size was calculated by using power analysis for two proportions to reach a statistical power of more than 80% to detect differences of 5%, using the assumption of 16 ± 12 g scar tissue for patients with chronic myocardial infarction, and 9 ± 5 g for HCM and inflammatory heart disease which were reported previously by our group [26].

Image quality scores were compared by using the Mann-Whitney U test. Interobserver and intraobserver agreement was assessed by using Cohen k statistics.

Statistical comparison of means of LGE size in each individual multi-slice technique against the segmented reference standard technique was performed by using two-tailed paired t tests and Bland-Altman analysis. Scar tissue percentages per segment, CNR and signal enhancement ratios were assessed using the Wilcoxon signed rank test, as these values did not show normal distribution.


Patient characteristics

In total, 312 patients were recruited. Fourteen of these patients were excluded due to incomplete image acquisition. All remaining 298 patients were successfully scanned using all techniques and were included in subsequent analyses (203 patients with chronic myocardial infarction, 50 patients with HCM and 45 patients with inflammatory heart disease). Patient characteristics are shown in Table 2. Study individuals with inflammatory heart disease were significantly younger than patients in the other groups. HCM patients had an increased LVM index (LVM-I), decreased LVEDV index (LVEDV-I) and a slightly elevated LVEF. Figure 1 shows representative images of LGE short axis slices for each group and each sequence.

Table 2 Patient Characteristics
Fig. 1
figure 1

Representative LGE images. Three selected patients with chronic myocardial infarction (a-d), hypertrophic cardiomyopathy (e-h) and acute myocarditis (i-l) with typical LGE localization: subendocardial for infarction, patchy intramural for HCM and subepicardial for myocarditis. Horizontal rows display corresponding slices of LGE in the same patient, vertical columns show the used techniques: conventional segmented FLASH-PSIR (a;e;i), multi-slice bSSFP-IR (b;f;j), multi-slice bSSFP-PSIR with breathhold (c;g;k) and free-breathing multi-slice bSSFP-IR (d;h;l). nonbh = non-breathhold

Acquisition time

The average scan time was significantly longer for the reference standard sequence (361.5 ± 95.3 s including breaks between slice acquisitions) than for any multi-slice sequence (SSFP-IR: 23.4 ± 7.2 s; SSFP-PSIR: 21.9 ± 6.4 s, p < 0.01 of all sequences against reference standard).

Image quality assessment

Image quality scores differed significantly between each multi-slice and the reference standard sequence. However, they were not influenced by disease entity or – regarding bSSFP-PSIR sequence – breathhold versus free breathing acquisition. Overall, bSSFP-PSIR images showed the best image quality scores. (Fig. 2).

Fig. 2
figure 2

Image quality scores. Values represent average image quality score for all patients in each group. Score system: 1 = excellent quality, no artifacts; 2 = good quality, minimal artifacts; 3 = moderate quality, some artifacts which may impair diagnostic quality; 4 = poor quality, unacceptable artifacts. * p < 0.05 within sequence. ** p < 0.05 towards FLASH-PSIR. ns = non-significant, p > 0.05. SR = sinus rhythm

Arrhythmia had a negative impact on image quality scores on the segmented FLASH-PSIR sequence, resulting in poor or non-diagnostic image quality in 48,8% of all patients. Image quality score was not influenced by arrhythmia in any multi-slice sequence.

Assessment of infarcted-to-remote area CNR is shown in Table 3. Mean infarcted-to-remote myocardium CNR was significantly higher on bSSFP-PSIR than on reference standard sequences (p < 0.01), and on bSSFP-IR lower than reference standard (p < 0.01). Free breathing acquisition of bSSFP-PSIR slightly decreased mean infarcted-to-remote area CNR as compared to acquisition under breathhold, however, was still superior to reference standard (p < 0.01). LGE due to chronic infarction showed significantly higher CNR values in all sequences than LGE due to HCM or inflammatory heart disease (p < 0.01).

Table 3 Contrast-to-noise ratios

Qualitative LGE analysis

Using reference standard sequence, 201 patients (67.4%) had detectable LGE (n = 143 with chronic infarction, n = 31 with HCM and n = 27 with inflammatory heart disease). All 201 LGE-positive patients also had detectable LGE on bSSFP-IR. With both bSSFP-PSIR sequences, two small LGE lesions (< 1 g scar size) were visually not detected in one patient with chronic infarction and one patient with HCM by two blinded readers.

On visual assessment, circumferential extent of scars was similar in all sequences; summation of scores showed excellent matching with reference standard FLASH-PSIR sequence (total score 3875) for bSSFP-PSIR with (total score 3903) and without breathhold (total score 3886) while on bSSFP-IR circumferential scar extent was slightly underestimated (total score 3726). Details are shown in Fig. 3a.

Fig. 3
figure 3

Visual assessment of LGE. a: Visual assessment of circumferential LGE extent. Columns represent number of segments with LGE for different circumferential extents across all study groups (chronic myocardial infarctions, HCM, inflammatory heart disease). b: Visual assessment of in-wall LGE location

On all multi-slice sequences, the visual allocation of LGE within the myocardial wall (subendocardial, subepicardial, intramural, transmural) showed good matching with FLASH-PSIR for the chronic infarction and inflammatory heart disease group while for inflammatory heart disease there was a higher number of visually transmural LGE areas on bSSFP-PSIR versus FLASH-PSIR (14% versus 10% segments with transmural LGE, see Fig. 3b).

Quantitative LGE analysis

There were no significant differences in mean LGE size between reference standard FLASH-PSIR and multi-slice sequences independent from LGE origin (Table 4). However, Bland-Altman analysis showed that on bSSFP-PSIR LGE size showed a non-significant trend to be smaller in all study groups compared to reference standard - mean difference in LGE size towards reference standard being 0.58 ± 1.99 g on bSSFP-PSIR with breathhold, 0.96 ± 2.03 g on bSSFP-PSIR with free breathing and 0.26 ± 2.4 g on bSSFP-IR (see Fig. 4 for Bland-Altman plots).

Table 4 Quantitative Assessment - LGE size
Fig. 4
figure 4

Bland-Altman plots of LGE mass. Blue dots represent mean LGE size (x-axis) versus delta LGE mass towards FLASH-PSIR (y-axis) in gram for each LGE sequence

The presence or absence of breathhold during LGE imaging using bSSFP-PSIR had no impact on LGE size for any disease entity (Table 4).

Intraobserver agreement (Pearson coefficient) on LGE size was > 0.95 for all sequences. Interobserver agreement was 0.92 for bSSFP-PSIR under free breathing and 0.88 for all other sequences.

In patients with arrhythmia during image acquisition mean LGE size did not differ in any multi-slice sequence, with bSSFP-IR 7.6 ± 6.1 g and bSSFP-PSIR 7.7 ± 5.6 g under breathhold and 7.4 ± 5.6 g under free breathing. Reference standard FLASH-PSIR sequence was not evaluated in arrhythmic patients due to mostly non-diagnostic image quality.


The present study compared for the first time a reference standard segmented (FLASH-PSIR) with two multi-slice LGE sequences (bSSFP-IR and bSSFP-PSIR) in 298 patients with ischemic and non-ischemic cardiomyopathies.

Our key findings were: Firstly, image quality and CNR were highest on multi-slice bSSFP-PSIR with and without breathhold. Secondly, acquisition time is relevantly shorter on any multi-slice sequence compared to reference standard. Thirdly, visual detection of LGE and visual assessment of LGE extent was consistently very good and equivalent in all sequences. Fourthly, quantification showed no significant difference in LGE size for any multi-slice sequence. Fifthly, in patients with arrhythmia all multi-slice sequences generated good image quality and consistent LGE quantification results, whereas the reference standard provided non-diagnostic image quality in half of all exams. Finally, acquisition of bSSFP-PSIR under free breathing or under breathhold had no impact on LGE detection and quantification. Results were independent of the cause of LGE from ischemic or non-ischemic etiology.

The assessment of myocardial fibrosis has enormous diagnostic and prognostic impact in ischemic and non-ischemic cardiomyopathy [5,6,7]. Over the last decade many clinical studies have paved the way for CMR to be integrated into a variety of cardiologic, radiologic and other clinical guidelines [9]. The role of LGE in detection of myocardial fibrosis remains unequivocally important despite the development of new parametric mapping techniques, which play an increasing role especially in detection of diffuse fibrosis [28, 29].

Our study demonstrates that bSSFP-PSIR and bSSFP-IR multi-slice LGE sequences provide excellent alternatives to segmented FLASH-PSIR in routine CMR protocols. We showed that not only for ischemic LGE lesions but also for more diffuse lesions in inflammatory heart disease or HCM multi-slice sequences are sufficient to visualize fibrosis and – when quantified in size – show equivalent results compared to the reference standard. The equivalence of multi-slice LGE sequences to segmented sequences has previously been shown in studies for either HCM, ischemic or inflammatory heart disease [18, 19, 30]. However, these studies each used different sequences, smaller patient groups and mostly looked at single disease entities.

The superiority of multi-slice over segmented PSIR sequences in regard to image quality and CNR is in line with other publications [18, 19]. This is attributable to the reduction of motion artifacts and artifacts due to arrhythmia. CNR also depends on the amount of gadolinium-based contrast media in the myocardium, which is influenced by amount and molarity of contrast agent, distribution volume and hemodynamics. As we strictly dosed gadolinium to body weight and tested sequences in a random order, effects on results should be neglectable.

We have also seen variations in CNR between the different disease entities. Since CNR is dependent on the voxel composition of fibrotic tissue, LGE in chronic infarction with more compact fibrosis is expected to result in higher CNR values than LGE in more diffusely fibrotic tissue such as in HCM and inflammatory heart disease.

On bSSFP-PSIR sequence visual assessment revealed slightly larger scar transmurality as compared to the reference standard. We believe that visual assessment of bSSFP-PSIR images is impacted by its comparably higher CNR values which may lead to subjectively higher transmurality of scars.

In two patients, small LGE lesions detectable with the reference standard sequence, were not detected with multi-slice bSSFP-PSIR but, nevertheless, could be visualized with bSSFP-IR. Note that for these two patients LGE amount was less than one gram, which suggests that partial volume effects or shifted slice position due to heavy respiratory motion may have caused the missed lesion. However, it cannot be safely excluded that very small LGE lesions may be missed with multi-slice bSSFP-PSIR due to its different matrix size as compared to the reference standard.

It has been shown that even a small amount of LGE has prognostic implications in cardiomyopathies [31,32,33,34]. In case of inflammatory heart disease missed small subepicardial LGE may even impact diagnosis [35], as Lake Louise criteria define myocarditis as two out of three parameters, LGE being one of them [36].

Our results suggest that in patients with known or suspected myocardial infarction bSSFP-PSIR or bSSFP-IR multi-slice sequences can be primarily utilized for LGE detection. In case of an unknown cardiomyopathy or for assessment of HCM and inflammatory heart disease segmented FLASH-PSIR images should be used in scenarios of stable sinus rhythm and sufficient breathhold capabilities. For patients with arrhythmia and/or insufficient breathhold capabilities at the time of CMR scan we showed that segmented sequences fail to provide sufficient image quality. This is in line with previous studies [37, 38]. In these patients we suggest to primarily use multi-slice sequences such as bSSFP-PSIR and/or bSSFP-IR.

In this study two different contrast media were used; gadoteridol in CAD and HCM patients and gadopentate for inflammatory heart disease. The reason for use of gadopentate was established normal values for relative enhancement sequences, which were acquired in these patients independently from this study. However, there is good evidence that relaxivity and contrast enhancement are nearly identical for both agents so that impact on results should be neglectable. [39]

In our study we explicitly did not exclude patients with arrhythmia. We demonstrated good to excellent image quality and equivalent amount of LGE quantification with all multi-slice sequences. There is no gold standard for LGE detection and quantification in arrhythmic patients. Hence, we cannot definitely state that results are perfectly correct using multi-slice sequences. Still, due to the consistently high image quality scores and – as compared to patients with sinus rhythm – similar CNR values we feel confident that usage of any multi-slice sequence is superior to attempts of segmented image acquisition and shortens scan protocols significantly in these patients.

Interestingly, presence or absence of breathhold during image acquisition on bSSFP-PSIR did not affect detection or quantification of LGE across all study groups. While there must be minimal slice shifting due to respiratory motion on acquisition of an entire LV short axis package within approximately 20 s of acquisition time we could show in a large number of patients that this has no statistically significant effect on diagnostic value. Lower numbers of breathhold cycles may also positively affect patient comfort and may be considered in all patients when SSFP-PSIR sequence is used.

Alternative methods for LGE assessment include 3D sequences, which have been shown to also accurately visualize fibrosis and scarring [40, 41]. These 3D sequences have the advantage of potentially higher spatial resolution, especially in the vertical axis, and the possibility of free movement through the ventricular myocardium. On the other hand, 3D sequences typically require a relatively long acquisition time. This necessitates a continuous adaptation of the optimal myocardial inversion time, which may impair image quality and CNR. Implementation of 3D LGE sequences with dynamic inversion time adjustments may help to overcome this obstacle [42].

In another recent study dark blood PSIR imaging was published using T2 preparation pulses for improved visualization of fibrosis close to the adjacent LV blood pool in 30 patients with subendocardial infarction [43]. This promising technique also included motion correction for acquisition under free breathing but needs to be validated across myocardial disease entities in larger studies.


LGE sequences are a mandatory part of most CMR protocols in ischemic and non-ischemic cardiomyopathy [8]. The broader spread of CMR in clinical routine has several implications: demand for CMR access increases and there is a continuous need for fast scanning protocols [14]. While segmented LGE sequences may give excellent image quality under stable sinus rhythm and sufficient breathhold the issue of time investment prevails. We demonstrated equivalence of multi-slice LGE sequences (bSSFP-IR and bSSFP-PSIR) and segmented FLASH-PSIR sequence in a large number of patients with ischemic and non-ischemic cardiac disease.

For that reason we suggest further strengthening the role of multi-slice sequences in routine CMR protocols whenever it is reliable to use.


In spite of the large patient number in this study, all patients were scanned and analyzed in a single CMR center. Male gender was overrepresented in all study groups. Comparability of LGE sequences maybe impacted by different matrix size and, hence, different in-plane resolution used for each sequence. This may also affect SNR and CNR as well as assessment of LGE-positive areas.





American Heart Association


Body mass index


Balanced steady-state free precession


Cardiovascular magnetic resonance


Contrast-to-noise ratio


Fast low angle shot


Hypertrophic cardiomyopathy


Heart rate


Inversion recovery


Late gadolinium enhancement


Left ventricle/left ventricular


Left ventricular end-diastolic volume


Left ventricular end-diastolic volume index


Left ventricular ejection fraction


Left ventricular mass


Left ventricular mass index


Magnetic resonance


Non-breathhold (free breathing)


Phase-sensitive inversion recovery




Right ventricle/right ventricular


Standard deviation


Signal-to-noise ratio


Sinus rhythm


Semi-automated signal threshold versus reference mean


Stroke volume index


Echo time


Inversion time


  1. Kim RJ, Wu E, Rafael a, Chen EL, Parker MA, Simonetti O, Klocke FJ, Bonow RO, Judd RM. the use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445–53.

    Article  CAS  PubMed  Google Scholar 

  2. Saeed M, Weber O, Lee R, Do L, Martin A, Saloner D, Ursell P, Robert P, Corot C, Higgins CB. Discrimination of myocardial acute and chronic (scar) infarctions on delayed contrast enhanced magnetic resonance imaging with intravascular magnetic resonance contrast media. J Am Coll Cardiol. 2006;48(10):1961–8.

    Article  PubMed  Google Scholar 

  3. Bondarenko O, Beek AM, Nijveldt R, McCann GP, van Dockum WG, Hofman MB, Twisk JW, Visser CA, van Rossum AC. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2007;9(5):815–21.

    Article  Google Scholar 

  4. Fluechter S, Kuschyk J, Wolpert C, Doesch C, Veltmann C, Haghi D, Schoenberg SO, Sueselbeck T, Germans T, Streitner F, et al. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2010;12:30.

    Article  Google Scholar 

  5. Adabag AS, Maron BJ, Appelbaum E, Harrigan CJ, Buros JL, Gibson CM, Lesser JR, Hanna CA, Udelson JE, Manning WJ, et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol. 2008;51(14):1369–74.

    Article  PubMed  Google Scholar 

  6. Ise T, Hasegawa T, Morita Y, Yamada N, Funada A, Takahama H, Amaki M, Kanzaki H, Okamura H, Kamakura S, et al. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart. 2014;100(15):1165–72.

    Article  CAS  PubMed  Google Scholar 

  7. Neilan TG, Shah RV, Abbasi SA, Farhad H, Groarke JD, Dodson JA, Coelho-Filho O, McMullan CJ, Heydari B, Michaud GF, et al. The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation. J Am Coll Cardiol. 2013;62(23):2205–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Society For cardiovascular magnetic resonance Board of Trustees Task Force on standardized P: standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2013;15:91.

    Article  Google Scholar 

  9. von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2016;18:6.

    Article  Google Scholar 

  10. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Revista espanola de cardiologia. 2016;69(12):1167.

    Article  PubMed  Google Scholar 

  11. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of. Magn Reson Med. 2002;47(2):372–83.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Simonetti OP, Kim RJ, Fieno DS, Hillenbrand HB, Wu E, Bundy JM, Finn JP, Judd RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218(1):215–23.

    Article  CAS  PubMed  Google Scholar 

  13. Sievers B, Rehwald WG, Albert TS, Patel MR, Parker MA, Kim RJ, Judd RM. Respiratory motion and cardiac arrhythmia effects on diagnostic accuracy of myocardial delayed-enhanced MR imaging in canines. Radiology. 2008;247(1):106–14.

    Article  PubMed  Google Scholar 

  14. Muehlberg F, Neumann D, Von Knobelsdorff-Brenkenhoff F, Traber J, Alwardt N, Schulz-Menger J. a multicenter cardiovascular MR network for tele-training and beyond: setup and initial experiences. Journal of the American College of Radiology : JACR. 2015;12(8):876–83.

    Article  PubMed  Google Scholar 

  15. Hendel RC, Friedrich MG, Schulz-Menger J, Zemmrich C, Bengel F, Berman DS, Camici PG, Flamm SD, Le Guludec D, Kim R, et al. CMR first-pass perfusion for suspected inducible myocardial ischemia. JACC Cardiovascular imaging. 2016;9(11):1338–48.

    Article  PubMed  Google Scholar 

  16. Sievers B, Elliott MD, Hurwitz LM, Albert TS, Klem I, Rehwald WG, Parker MA, Judd RM, Kim RJ. Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation. 2007;115(2):236–44.

    Article  PubMed  Google Scholar 

  17. Nguyen TD, Spincemaille P, Weinsaft JW, Ho BY, Cham MD, Prince MR, Wang Y. A fast navigator-gated 3D sequence for delayed enhancement MRI of the myocardium: comparison with breathhold 2D imaging. Journal of magnetic resonance imaging : JMRI. 2008;27(4):802–8.

    Article  PubMed  Google Scholar 

  18. Viallon M, Jacquier A, Rotaru C, Delattre BM, Mewton N, Vincent F, Croisille P. Head-to-head comparison of eight late gadolinium-enhanced cardiac MR (LGE CMR) sequences at 1.5 tesla: from bench to bedside. Journal of magnetic resonance imaging : JMRI. 2011;34(6):1374–87.

    Article  PubMed  Google Scholar 

  19. Morita K, Utsunomiya D, Oda S, Komi M, Namimoto T, Hirai T, Hashida M, Takashio S, Yamamuro M, Yamashita Y. Comparison of 3D phase-sensitive inversion-recovery and 2D inversion-recovery MRI at 3.0 T for the assessment of late gadolinium enhancement in patients with hypertrophic cardiomyopathy. Acad Radiol. 2013;20(6):752–7.

    Article  PubMed  Google Scholar 

  20. Thiele H, Paetsch I, Schnackenburg B, Bornstedt A, Grebe O, Wellnhofer E, Schuler G, Fleck E, Nagel E. Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2002;4(3):327–39.

    Article  Google Scholar 

  21. Rudolph A, Messroghli D, Von Knobelsdorff-Brenkenhoff F, Traber J, Schuler J, Wassmuth R, Schulz-Menger J. prospective, randomized comparison of gadopentetate and gadobutrol to assess chronic myocardial infarction applying cardiovascular magnetic resonance. BMC Med Imaging. 2015;15(1):55.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Gupta A, Lee VS, Chung YC, Babb JS, Simonetti OP. Myocardial infarction: optimization of inversion times at delayed contrast-enhanced MR imaging. Radiology. 2004;233(3):921–6.

    Article  PubMed  Google Scholar 

  23. Dietrich O, Raya JG, Reeder SB, Reiser MF, Schoenberg SO. Measurement of signal-to-noise ratios in MR images: influence of multichannel coils, parallel imaging, and reconstruction filters. Journal of magnetic resonance imaging : JMRI. 2007;26(2):375–85.

    Article  PubMed  Google Scholar 

  24. Kino A, Zuehlsdorff S, Sheehan JJ, Weale PJ, Carroll TJ, Jerecic R, Carr JC. Three-dimensional phase-sensitive inversion-recovery turbo FLASH sequence for the evaluation of left ventricular myocardial scar. AJR Am J Roentgenol. 2009;193(5):W381–8.

    Article  PubMed  Google Scholar 

  25. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM, Nassenstein K, Schlosser T, Sabin GV, Sechtem U, et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2010;56(11):875–87.

    Article  PubMed  Google Scholar 

  26. Rudolph A, Von Knobelsdorff-Brenkenhoff F, Wassmuth R, Prothmann M, Utz W, Schulz-Menger J. assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging. Journal of magnetic resonance imaging : JMRI. 2014;39(5):1153–60.

    Article  PubMed  Google Scholar 

  27. Mikami Y, Kolman L, Joncas SX, Stirrat J, Scholl D, Rajchl M, Lydell CP, Weeks SG, Howarth AG, White JA. Accuracy and reproducibility of semi-automated late gadolinium enhancement quantification techniques in patients with hypertrophic cardiomyopathy. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2014;16:85.

    Article  Google Scholar 

  28. Messroghli DR, Nordmeyer S, Dietrich T, Dirsch O, Kaschina E, Savvatis K, D oh-I KC, Berger F, Kuehne T. assessment of diffuse myocardial fibrosis in rats using small-animal look-locker inversion recovery T1 mapping. Circulation Cardiovascular imaging. 2011;4(6):636–40.

    Article  PubMed  Google Scholar 

  29. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified look-locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of. Magn Reson Med. 2004;52(1):141–6.

    Article  PubMed  Google Scholar 

  30. Kellman P, Larson AC, Hsu LY, Chung YC, Simonetti OP, McVeigh ER, Arai AE. Motion-corrected free-breathing delayed enhancement imaging of myocardial infarction. Magn Reson Med. 2005;53(1):194–200.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Mikami Y, Cornhill A, Heydari B, Joncas SX, Almehmadi F, Zahrani M, Bokhari M, Stirrat J, Yee R, Merchant N, et al. Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular events. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2016;18(1):82.

    Article  Google Scholar 

  32. Lee SA, Yoon YE, Kim JE, Park JJ, Oh IY, Yoon CH, Suh JW, Kim JS, Chun EJ, Cho YS, et al. Long-term prognostic value of late gadolinium-enhanced magnetic resonance imaging in patients with and without left ventricular dysfunction undergoing coronary artery bypass grafting. Am J Cardiol. 2016;118(11):1647–54.

    Article  PubMed  Google Scholar 

  33. Hulten E, Agarwal V, Cahill M, Cole G, Vita T, Parrish S, Bittencourt MS, Murthy VL, Kwong R, Di Carli MF, et al. Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis. Circulation Cardiovascular imaging. 2016;9(9):e005001.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Chan RH, Maron BJ, Olivotto I, Pencina MJ, Assenza GE, Haas T, Lesser JR, Gruner C, Crean AM, Rakowski H, et al. Prognostic value of quantitative contrast-enhanced cardiovascular magnetic resonance for the evaluation of sudden death risk in patients with hypertrophic cardiomyopathy. Circulation. 2014;130(6):484–95.

    Article  PubMed  Google Scholar 

  35. Grun S, Schumm J, Greulich S, Wagner A, Schneider S, Bruder O, Kispert EM, Hill S, Ong P, Klingel K, et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol. 2012;59(18):1604–15.

    Article  PubMed  Google Scholar 

  36. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, White JA, Abdel-Aty H, Gutberlet M, Prasad S, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol. 2009;53(17):1475–87.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Knowles BR, Caulfield D, Cooklin M, Rinaldi CA, Gill J, Bostock J, Razavi R, Schaeffter T, Rhode KS. 3-D visualization of acute RF ablation lesions using MRI for the simultaneous determination of the patterns of necrosis and edema. IEEE Trans Biomed Eng. 2010;57(6):1467–75.

    Article  PubMed  Google Scholar 

  38. Weingartner S, Akcakaya M, Basha T, Kissinger KV, Goddu B, Berg S, Manning WJ, Nezafat R. Combined saturation/inversion recovery sequences for improved evaluation of scar and diffuse fibrosis in patients with arrhythmia or heart rate variability. Magn Reson Med. 2014;71(3):1024–34.

    Article  PubMed  Google Scholar 

  39. Rinck PA, Muller RN. Field strength and dose dependence of contrast enhancement by gadolinium-based MR contrast agents. Eur Radiol. 1999;9(5):998–1004.

    Article  CAS  PubMed  Google Scholar 

  40. Kido T, Kido T, Nakamura M, Kawaguchi N, Nishiyama Y, Ogimoto A, Miyagawa M, Mochizuki T. Three-dimensional phase-sensitive inversion recovery sequencing in the evaluation of left ventricular myocardial scars in ischemic and non-ischemic cardiomyopathy: comparison to three-dimensional inversion recovery sequencing. Eur J Radiol. 2014;83(12):2159–66.

    Article  PubMed  Google Scholar 

  41. Morsbach F, Gordic S, Gruner C, Niemann M, Goetti R, Gotschy A, Kozerke S, Alkadhi H, Manka R. Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy. Int J Cardiol. 2016;217:167–73.

    Article  CAS  PubMed  Google Scholar 

  42. Keegan J, Gatehouse PD, Haldar S, Wage R, Babu-Narayan SV, Firmin DN. Dynamic inversion time for improved 3D late gadolinium enhancement imaging in patients with atrial fibrillation. Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of. Magn Reson Med. 2015;73(2):646–54.

    Article  CAS  PubMed  Google Scholar 

  43. Kellman P, Xue H, Olivieri LJ, Cross RR, Grant EK, Fontana M, Ugander M, Moon JC, Hansen MS. Dark blood late enhancement imaging. Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance. 2016;18(1):77.

    Article  Google Scholar 

Download references


We sincerely acknowledge the support of our CMR technicians Denise Kleindienst, Kerstin Kretschel and Evelyn Polzin as well as our study nurses Annette Köhler-Rohde and Elke Nickel-Szczech in conducting all study scans. We sincerely thank Carsten Schwenke PhD for his continuous support in matters of study statistics and power calculation throughout this study. We also acknowledge the help of Johannes Kuttner during internal manuscript review.

Consent for study participation

Study individuals have given their written consent for participating in this study.


No external funding has been received for the realization of this study.

Availability of data and materials

The datasets analyzed during the current study are available from the corresponding author upon reasonable request. Original imaging data are not publicly available due to lawful data protection in Germany.

Author information

Authors and Affiliations



FM developed study design, applied for ethic board approval, conducted major part of CMR scans, led image analysis and data interpretation and was the major contributor in writing the manuscript. KA conducted major parts of image analysis and statistical data interpretation. SiF was involved in image analysis and manuscript writing. StF was involved in image analysis and manuscript writing. MP conducted CMR scans and was involved in image analysis. JK was involved in image analysis and manuscript writing. LZ was involved in data analysis and manuscript writing. FK was involved in data analysis and manuscript writing. JS supervised overall study design, ensured quality control on image analysis and data interpretation, supervised manuscript writing and provided continuous guidance throughout study realization as head of the working group. All authors have read and approved the final manuscript.

Corresponding author

Correspondence to Fabian Muehlberg.

Ethics declarations

Ethics approval and consent to participate

The study was approved by Charité University Medicine ethics board at Charité Campus Mitte, Berlin, Germany.

Consent for publication

Individuals have given their written consent for anonymous publication.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Muehlberg, F., Arnhold, K., Fritschi, S. et al. Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy – a prospective clinical cardiovascular magnetic resonance trial. J Cardiovasc Magn Reson 20, 13 (2018).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: